Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes

New Developments in Insulin Therapy for Type 2 Diabetes

(2014) Christopher Sorli   AMERICAN JOURNAL OF MEDICINE

Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)

(2014) John B. Buse et al.   DIABETES CARE

Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus

(2014) Lesley J. Scott   DRUGS

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations

(2014) Nicholas W. Carris et al.   DRUGS

Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy

(2014) Ajay Kumar   EXPERT OPINION ON BIOLOGICAL THERAPY

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

(2014) Conrad Eng et al.   LANCET

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

(2014) Stephen C L Gough et al.   Lancet Diabetes & Endocrinology

Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes

(2013) Stuart A. Ross   AMERICAN JOURNAL OF MEDICINE

Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review

(2013) Ronald Goldenberg   CURRENT MEDICAL RESEARCH AND OPINION

Insulin Degludec and Insulin Degludec/Insulin Aspart: A Review of Their Use in the Management of Diabetes Mellitus

(2013) Gillian M. Keating   DRUGS

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE